SHG:603351 - Nanjing Well Pharmaceutical Group Co Ltd Nanjing Well Pharmaceutical Gr
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)
Annual TTM
Balance Sheet Cash Flow Income Statement Key Ratios
Adjust Display Metrics

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2017 Q2 2017 Q3 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 Graph
Total Assets [friend] [friend] [friend] [friend] [friend] [friend] 808.2M
3.8%
1.39B
71.5%
1.38B
-0.4%
1.46B
5.4%
1.46B
0.2%
1.48B
1.6%
1.51B
1.7%
1.55B
3.1%
1.64B
5.3%
1.69B
3.4%
1.68B
-0.5%
-
Total Liabilities [friend] [friend] [friend] [friend] [friend] [friend] 193.59M
1.1%
194.91M
0.7%
190.38M
-2.3%
231.55M
21.6%
217.06M
-6.3%
207.76M
-4.3%
249.94M
20.3%
278.68M
11.5%
336.75M
20.8%
366.46M
8.8%
365.98M
-0.1%
-
Total Equity [friend] [friend] [friend] [friend] [friend] [friend] 614.61M
4.7%
1.19B
93.8%
1.19B
-0.1%
1.22B
2.8%
1.24B
1.4%
1.27B
2.6%
1.26B
-1.3%
1.28B
1.5%
1.3B
1.9%
1.33B
2.1%
1.32B
-0.6%
-
Operating CashFlow [friend] [friend] [friend] [friend] [friend] [friend] 5.82M
-66.1%
- - - - - - - - - - -
Investing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] -12.8M
-
-10.72M
-
-342.29M
-
-40.65M
-
-102.03M
-
-60.15M
-
-20.23M
-
-4.76M
-
-80.29M
-
47.03M
-
-20.17M
-
-47.2M
-
Financing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] -7.88M
-
546.14M
-
-37.34M
-
2.07M
-
-1.96M
-
14.09M
-
-37.65M
-
-18M
-
8.95M
-
53.61M
498.7%
-28.35M
-
88.66M
-
Beginning Cash Position [friend] [friend] [friend] [friend] [friend] [friend] 52.44M
-35.0%
37.59M
-28.3%
607.04M
1514.9%
250.17M
-58.8%
250.26M
0.0%
180.93M
-27.7%
155.71M
-13.9%
130.21M
-16.4%
117.29M
-9.9%
75.56M
-35.6%
150.06M
98.6%
71.58M
-52.3%
End Cash Position [friend] [friend] [friend] [friend] [friend] [friend] 37.59M
-28.3%
607.04M
1514.9%
250.17M
-58.8%
250.26M
0.0%
180.93M
-27.7%
155.71M
-13.9%
130.21M
-16.4%
117.29M
-9.9%
75.56M
-35.6%
150.06M
98.6%
71.58M
-52.3%
90.78M
26.8%
Free CashFlow [friend] [friend] [friend] [friend] [friend] [friend] -7.5M
-
25.84M
-
-37.79M
-
18.6M
-
2.43M
-86.9%
-28.46M
-
-21.61M
-
-72.96M
-
-66.1M
-
-139.41M
-
-75.03M
-
-62.7M
-
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] 201.54M
4.7%
212.74M
5.6%
225.05M
5.8%
222.94M
-0.9%
220.03M
-1.3%
155.41M
-29.4%
176.86M
13.8%
179.36M
1.4%
224.44M
25.1%
227.43M
1.3%
257.36M
13.2%
279.41M
8.6%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] 27.71M
20.8%
- - - - - - - - - - -
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] - - - - - - - - - - - -
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] 0.286
21.2%
0.314
10.0%
0.286
-9.1%
0.26
-9.0%
0.14
-46.2%
0.24
71.4%
0.2
-16.7%
0.14
-30%
0.19
35.7%
0.2
5.3%
0.23
15%
0.21
-8.7%
Net Margin [friend] [friend] [friend] [friend] [friend] [friend] 13.75%
15.3%
17.94%
30.5%
17.04%
-5.0%
15.19%
-10.8%
8.06%
-47.0%
20.71%
157.0%
14.28%
-31.0%
10.12%
-29.1%
11.07%
9.4%
11.52%
4.1%
11.77%
2.1%
9.79%
-16.8%
Return On Equity [friend] [friend] [friend] [friend] [friend] [friend] 4.61%
15.7%
4.23%
-8.4%
3.22%
-23.8%
2.81%
-12.8%
1.44%
-48.7%
2.56%
77.9%
2%
-22.0%
1.43%
-28.2%
1.93%
34.6%
2%
3.4%
2.29%
14.8%
-
Return On Assets [friend] [friend] [friend] [friend] [friend] [friend] 3.49%
19.3%
3.48%
-0.4%
2.77%
-20.3%
2.39%
-13.8%
1.22%
-49.1%
2.19%
79.9%
1.69%
-22.8%
1.19%
-29.8%
1.56%
31.3%
1.57%
1.1%
1.79%
13.9%
-
Values are in CNY whenever applicable | Fiscal year ends on December 31
Powered by Morningstar